✦ LIBER ✦

P96 Biostatistical/clinical issues in global drug development

✍ Scribed by Jay Herson; Michael Silverman

Book ID: 113298366
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 74 KB
Volume: 16
Category: Article
ISSN: 0197-2456
DOI: 10.1016/0197-2456(95)90576-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Global issues in drug development for Al

Global issues in drug development for Alzheimer’s disease

✍ Rachelle S. Doody; Patricia E. Cole; David S. Miller; Eric Siemers; Ronald Black 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 459 KB

The issues to be considered in global dr

The issues to be considered in global drug development

✍ Masahiro Takeuchi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 27 KB

Allometric issues in drug development

✍ Iftekhar Mahmood 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Clinical forecasting in drug development

✍ Schachter, Asher D.; Ramoni, Marco F. 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 166 KB

Biomarkers in Clinical Drug Development

✍ Gobburu, JVS 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 82 KB

Emerging and recurrent issues in drug de

Emerging and recurrent issues in drug development

✍ Charles Anello 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

This paper reviews several emerging and recurrent issues relating to the drug development process. These emerging issues include changes to the FDA regulatory environment, internationalization of drug development, advances in computer technology and visualization tools, and e!orts to incorporate met